NOD1 mediates non-canonical inflammasome processing of interleukin-18 in epithelial cells to Helicobacter pylori infection
暂无分享,去创建一个
D. Philpott | K. Elgass | S. Masters | B. Croker | A. Mansell | L. Ying | J. Dowling | T. Kufer | H. Abud | S. Creed | J. S. Pedersen | M. Kaparakis-Liaskos | K. D'Costa | R. Ferrero | C. Allison | J. Ferrand | P. Johanesen | L. S. Tran | U. Nachbur | L. Le | G. Kerr | G. Wray-McCann | H. Chaudhry | J. Emery | A. De Paoli | J. Como | Le Son Tran | Genevieve Kerr | Jonathan Ferrand | A. D. Paoli | Ashley Mansell | Kirstin Elgass | Helen E. Abud
[1] K. D'Costa,et al. Mouse Models Of Helicobacter Infection And Gastric Pathologies. , 2018, Journal of visualized experiments : JoVE.
[2] Andrea Reboldi,et al. Faculty Opinions recommendation of Inflammasomes: mechanism of assembly, regulation and signalling. , 2018, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[3] Si Ming Man. Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis , 2018, Nature Reviews Gastroenterology & Hepatology.
[4] J. Silke,et al. NOD1 is required for Helicobacter pylori induction of IL‐33 responses in gastric epithelial cells , 2018, Cellular microbiology.
[5] A. Loukas,et al. The NLRP3 Inflammasome Suppresses Protective Immunity to Gastrointestinal Helminth Infection. , 2018, Cell reports.
[6] X. Liang,et al. MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesis , 2018, Oncogene.
[7] K. Maloy,et al. Epithelial Cell Inflammasomes in Intestinal Immunity and Inflammation , 2017, Front. Immunol..
[8] V. Dixit,et al. Inflammasomes: mechanism of assembly, regulation and signalling , 2016, Nature Reviews Immunology.
[9] C. Maldonado-Bernal,et al. Activation of NLRP3 inflammasome in human neutrophils by Helicobacter pylori infection , 2016, Innate immunity.
[10] M. Febbraio,et al. IL-18 Production from the NLRP1 Inflammasome Prevents Obesity and Metabolic Syndrome. , 2016, Cell metabolism.
[11] E. Elinav,et al. Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis , 2015, Cell.
[12] I. Amit,et al. Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling , 2015, Cell.
[13] J. Malter,et al. The DNA Sensor AIM2 Maintains Intestinal Homeostasis via Regulation of Epithelial Antimicrobial Host Defense. , 2015, Cell reports.
[14] S. Backert,et al. Helicobacter urease-induced activation of the TLR2/NLRP3/IL-18 axis protects against asthma. , 2015, The Journal of clinical investigation.
[15] W. Hardt,et al. Inflammasomes of the intestinal epithelium. , 2015, Trends in immunology.
[16] Y. Joo,et al. Association between interleukin-18 gene polymorphism and Helicobacter pylori infection in the Korean population , 2015, Scientific Reports.
[17] Min-jun Yu,et al. Helicobacter pylori induces IL-1β and IL-18 production in human monocytic cell line through activation of NLRP3 inflammasome via ROS signaling pathway. , 2015, Pathogens and disease.
[18] Nick Barker,et al. Snai1 regulates cell lineage allocation and stem cell maintenance in the mouse intestinal epithelium , 2015, The EMBO journal.
[19] Giovanni Suarez,et al. Modification of Helicobacter pylori Peptidoglycan Enhances NOD1 Activation and Promotes Cancer of the Stomach. , 2015, Cancer research.
[20] T. Wang,et al. The MUC1 mucin protects against Helicobacter pylori pathogenesis in mice by regulation of the NLRP3 inflammasome , 2015, Gut.
[21] J. Sandow,et al. A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production , 2015, Nature Communications.
[22] J. Sirard,et al. Flagellin-induced NLRC4 phosphorylation primes the inflammasome for activation by NAIP5 , 2015, Proceedings of the National Academy of Sciences.
[23] D. Busch,et al. Helicobacter pylori–Induced IL-1β Secretion in Innate Immune Cells Is Regulated by the NLRP3 Inflammasome and Requires the Cag Pathogenicity Island , 2014, The Journal of Immunology.
[24] K. Maloy,et al. Nlrp3 Activation in the Intestinal Epithelium Protects against a Mucosal Pathogen , 2013, Mucosal Immunology.
[25] D. Forman,et al. The burden of stomach cancer in indigenous populations: a systematic review and global assessment , 2013, Gut.
[26] C. Dinarello,et al. Interleukin-18 and IL-18 Binding Protein , 2013, Front. Immunol..
[27] G. Núñez,et al. The Cag pathogenicity island and interaction between TLR2/NOD2 and NLRP3 regulate IL‐1β production in Helicobacter pylori infected dendritic cells , 2013, European journal of immunology.
[28] L. Lopetuso,et al. Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease , 2013, Front. Immunol..
[29] K. J. Henley,et al. NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells. , 2012, Immunity.
[30] J. Bertin,et al. NLRP6 Negatively Regulates Innate Immunity and Host Defense Against Bacterial Pathogens , 2012, Nature.
[31] W. Hardt,et al. Caspase-1 Has Both Proinflammatory and Regulatory Properties in Helicobacter Infections, Which Are Differentially Mediated by Its Substrates IL-1β and IL-18 , 2012, The Journal of Immunology.
[32] J. Tschopp,et al. NLRC4 inflammasomes in dendritic cells regulate noncognate effector function by memory CD8+ T cells , 2012, Nature Immunology.
[33] John Calvin Reed,et al. Identification of Inhibitors of NOD1-Induced Nuclear Factor-κB Activation , 2011, ACS medicinal chemistry letters.
[34] E. Elinav,et al. Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4 , 2010, Proceedings of the National Academy of Sciences.
[35] R. Peek,et al. Helicobacter pylori: gastric cancer and beyond , 2010, Nature Reviews Cancer.
[36] H. Herfarth,et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer , 2010, The Journal of experimental medicine.
[37] D. Philpott,et al. The innate immune molecule, NOD1, regulates direct killing of Helicobacter pylori by antimicrobial peptides , 2010, Cellular microbiology.
[38] N. Beauchemin,et al. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. , 2010, Immunity.
[39] B. Siegmund. Interleukin-18 in intestinal inflammation: friend and foe? , 2010, Immunity.
[40] M. Kastan,et al. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. , 2010, Immunity.
[41] C. Whitchurch,et al. Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells , 2010, Cellular microbiology.
[42] E. Kremmer,et al. Helicobacter pylori Induces MAPK Phosphorylation and AP-1 Activation via a NOD1-Dependent Mechanism1 , 2009, The Journal of Immunology.
[43] Y. Yamaoka,et al. Levels of interleukin-18 are markedly increased in Helicobacter pylori-infected gastric mucosa among patients with specific IL18 genotypes. , 2008, The Journal of infectious diseases.
[44] D. Graham,et al. Regulation of IL-18 in Helicobacter pylori Infection 1 , 2010 .
[45] D. Philpott,et al. NF-κB Activation during Acute Helicobacter pylori Infection in Mice , 2007, Infection and Immunity.
[46] E. Kremmer,et al. The pattern‐recognition molecule Nod1 is localized at the plasma membrane at sites of bacterial interaction , 2007, Cellular microbiology.
[47] P. Correa,et al. Carcinogenesis of Helicobacter pylori. , 2007, Gastroenterology.
[48] G. Núñez,et al. Nod1/RICK and TLR Signaling Regulate Chemokine and Antimicrobial Innate Immune Responses in Mesothelial Cells1 , 2007, The Journal of Immunology.
[49] G. Núñez,et al. RICK/RIP2 Mediates Innate Immune Responses Induced through Nod1 and Nod2 but Not TLRs1 , 2007, The Journal of Immunology.
[50] W. Leung,et al. H. pylori Genotypes and Cytokine Gene Polymorphisms Influence the Development of Gastric Intestinal Metaplasia in a Chinese Population , 2006, The American Journal of Gastroenterology.
[51] M. Washington,et al. Activation of β-catenin by carcinogenic Helicobacter pylori , 2005 .
[52] John Bertin,et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island , 2004, Nature Immunology.
[53] A. Godzik,et al. CARD6 Is a Modulator of NF-κB Activation by Nod1- and Cardiak-mediated Pathways* , 2003, Journal of Biological Chemistry.
[54] John Calvin Reed,et al. Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1. , 2002, Biochemical and biophysical research communications.
[55] Seamus J. Martin,et al. CARD games in apoptosis and immunity , 2002, EMBO reports.
[56] D. Philpott,et al. Reduced activation of inflammatory responses in host cells by mouse‐adapted Helicobacter pylori isolates , 2002, Cellular microbiology.
[57] A. Axon,et al. Expression of Interleukin-18, a Th1 cytokine, in human gastric mucosa is increased in Helicobacter pylori infection. , 2001, The Journal of infectious diseases.
[58] R. Beech,et al. cagE is a virulence factor associated with Helicobacter pylori-induced duodenal ulceration in children. , 2000, The Journal of infectious diseases.
[59] L. del Peso,et al. Nod1, an Apaf-1-like Activator of Caspase-9 and Nuclear Factor-κB* , 1999, The Journal of Biological Chemistry.
[60] M F Dixon,et al. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. , 1997, Gastroenterology.
[61] L. Ying,et al. Role of NOD1 and ALPK1/TIFA Signalling in Innate Immunity Against Helicobacter pylori Infection. , 2019, Current topics in microbiology and immunology.
[62] 酒井 恭子. Levels of interleukin-18 are markedly increased in Helicobacter pylori-infected gastric mucosa among patients with specific IL18 genotypes , 2010 .
[63] D. Philpott,et al. NF-kappaB activation during acute Helicobacter pylori infection in mice. , 2008, Infection and immunity.
[64] M. Washington,et al. Activation of beta-catenin by carcinogenic Helicobacter pylori. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[65] A. Godzik,et al. CARD6 is a modulator of NF-kappa B activation by Nod1- and Cardiak-mediated pathways. , 2003, The Journal of biological chemistry.
[66] S. Chen,et al. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. , 1999, The Journal of biological chemistry.